Canada Life’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,346
| Closed | -$37K | – | 2148 |
|
|
2024
Q1 | $37K | Hold |
2,346
| – | – | ﹤0.01% | 2042 |
|
|
2023
Q4 | $38K | Hold |
2,346
| – | – | ﹤0.01% | 2061 |
|
|
2023
Q3 | $30K | Hold |
2,346
| – | – | ﹤0.01% | 2093 |
|
|
2023
Q2 | $33K | Hold |
2,346
| – | – | ﹤0.01% | 2058 |
|
|
2023
Q1 | $36K | Hold |
2,346
| – | – | ﹤0.01% | 2115 |
|
|
2022
Q4 | $39K | Hold |
2,346
| – | – | ﹤0.01% | 2130 |
|
|
2022
Q3 | $43K | Hold |
2,346
| – | – | ﹤0.01% | 2127 |
|
|
2022
Q2 | $31K | Hold |
2,346
| – | – | ﹤0.01% | 2172 |
|
|
2022
Q1 | $23K | Hold |
2,346
| – | – | ﹤0.01% | 2331 |
|
|
2021
Q4 | $23K | Hold |
2,346
| – | – | ﹤0.01% | 2355 |
|
|
2021
Q3 | $80K | Hold |
2,346
| – | – | ﹤0.01% | 2104 |
|
|
2021
Q2 | $86K | Hold |
2,346
| – | – | ﹤0.01% | 2124 |
|
|
2021
Q1 | $104K | Hold |
2,346
| – | – | ﹤0.01% | 2093 |
|
|
2020
Q4 | $134K | Hold |
2,346
| – | – | ﹤0.01% | 2053 |
|
|
2020
Q3 | $120K | Hold |
2,346
| – | – | ﹤0.01% | 2001 |
|
|
2020
Q2 | $139K | Hold |
2,346
| – | – | ﹤0.01% | 1983 |
|
|
2020
Q1 | $97K | Hold |
2,346
| – | – | ﹤0.01% | 1984 |
|
|
2019
Q4 | $145K | Buy |
+2,346
| New | +$112K | ﹤0.01% | 1993 |
|
|
2019
Q3 | – | Sell |
-2,476
| Closed | -$56K | – | 2398 |
|
|
2019
Q2 | $56K | Hold |
2,476
| – | – | ﹤0.01% | 2413 |
|
|
2019
Q1 | $57K | Hold |
2,476
| – | – | ﹤0.01% | 2230 |
|
|
2018
Q4 | $50K | Buy |
+2,476
| New | +$60.9K | ﹤0.01% | 2379 |
|
Other funds holding DCPH
Canada Life's DCPH Position: Q2 2024 in Review
Canada Life sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 2,346 shares — an estimated $37K sold.
Canada Life first reported a position in DCPH in Q4 2018 and held it in 21 quarters. The position peaked at $145K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Canada Life reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Canada Life sold 2,346 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $37K.
- Canada Life first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 21 quarters.
- Canada Life's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $145K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Canada Life's 13F filing for Q2 2024, filed 12 Aug 2024.